NF-κB mediated transcription in human monocytic cells and endothelial cells

Trends in Cardiovascular Medicine

Volumn 8, Issue 3, 1998, Pages 138-142

  Parry, Graham C N ^a   Mackman, Nigel ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GLUCOCORTICOID; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID DERIVATIVE; SERINE PROTEINASE INHIBITOR; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0031948829     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00002-4     Document Type: Article

References (46)

1. Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, Winkler H: 1997. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-KB. J Clin Invest 99:763-772.
2. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
3. Baeuerle PA, Baltimore D: 1996. NF-κB: ten years after. Cell 87:13-20.
4. Beg AA, Baltimore D: 1996. An essential role for NF-KB in preventing TNF-α-induced cell death. Science 274:782-784.
5. Brand K, Page S, Rogler G, et al.: 1996. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97:1715-1722.
6. Brostjan C, Anrather J, Csizmadia V, et al.: 1996. Glucocorticoid-mediated repression of NF-κB activity in endothelial cells does not involve induction of IκBα synthesis. J Biol Chem 271:19,612-19,616.
7. Candipan RC, Wang B-Y, Buitrago R, Tsao PS, Cooke JP: 1996. Regression or progression. Dependency on vascular nitric oxide. Arterioscler Thromb Vase Biol 6:44-50.
8. Chen ZJ, Hagler J, Palombella VJ, et al.: 1995a. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteosome pathway. Genes Dev 9:1586-1597.
9. Chen CC, Rosenbloom CL, Anderson DC, Manning AM: 1995b. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intracellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol 155: 3538-3545.
10. Chen ZJ, Parent L, Maniatis T: 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
11. Cobb RR, Felts KA, Parry GCN, Mackman N: 1996. Proteosome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-KB. Eur J Immunol 26:839-845.
12. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 9:899-909.
13. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: 1992. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90:1168-1172.
14. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G: 1997. Glucocorticoid-mediated repression of nuclear factor-KB-dependent transcription involves direct interface with transactivation. Proc Natl Acad Sci USA 94:13504-13509.
15. De Caterina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK: 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68.
16. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: 1997. A cytokine-responsive IKB kinase that activates the transcription factor NF-κB. Nature 388: 548-554.
17. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T: 1997. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 94:2927-2932.
18. Kopp E, Ghosh S: 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959.
19. Lindner V, Collins T: 1996. Expression of NF-κB and IκB-α by aortic endothelium in an arterial injury model. Am J Pathol 148: 427-438.
20. Mackman N: 1994. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem 269:26,363-26,367.
21. Mauri N, Offermann MK, Swerlick R, et al.: 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and-expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874.
22. Mercurio F, Zhu H, Murray BW, et al.: 1997. IKK-I and IKK-2: cytokine-activated IκB kinases essential for NF-KB activation. Science 278:860-866.
23. Müller J, Ziegler-Heitbrock HWL, Baeuerle PA: 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiol 187:233-256.
24. Oeth P, Mackman N: 1995. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood 86:4144-4152.
25. Ollivier V, Parry GCN, Cobb RR, de Prost D, Mackman N: 1996. Elevated cyclic AMP inhibits NF-KB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271:20,828-20,835.
26. Parry GCN, Mackman N: 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 269: 20,823-20,825.
27. Parry GCN, Mackman N: 1997. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J Immunol 159:5450-5456.
28. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T: 1996. Salicylates inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 156:3961-3969.
29. Peng H-B, Libby P, Liao JK: 1995a. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J Biol Chem 270:14214-14219.
30. Peng H-B, Rajavashisth TB, Libby P, Liao JK: 1995b. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 270:17050-17055.
31. Read MA, Whitley MZ, Williams AJ, Collins T: 1994. NF-κB and iκB-α: an inducible regulatory system in endothelial activation. J Exp Med 179:503-512.
32. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T: 1995. The proteosome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 2: 493-506.
33. Régnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M: 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
34. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979.
35. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr: 1995. Role of transcriptional activation of IKBa in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
36. Schouten GJ, Vertegaal ACO, Whiteside ST, et al.: 1997. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J 16:3133-3144.
37. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA: 1992. Dithiocarbamates as potent inhibitors of nuclear factor KB activation in intact cells. J Exp Med 175:1181-1194.
38. Spieker M, Peng H-B, Liao JK: 1997. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα-. J Biol Chem 272:30969-30974.
39. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S: 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
40. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: 1995. Rel/NF-κB/ IκB family: intimate tales of association and dissociation. Genes Dev 9:2723-2735.
41. Whiteside ST, Epinat J-C, Rice NR, Israel A: 1997. I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J 16:1413-1426.
42. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV: 1997. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866-869.
43. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, de Martin R: 1996. Inhibition of endothelial cell activation by adeno-virus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J Exp Med 183:1013-1022.
44. Wulczyn FG, Krappmann D, Scheidereit C: 1996. The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation. J Mol Med 74:749-769.
45. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M: 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243-252.
46. Ziegler-Heitbrock HWL, Sternsdorf T, Liese J, et al.: 1993. Pyrrolidine dithiocarbamate inhibits NF-KB mobilization and TNF production in human monocytes. J Immunol 151:6986-6993.